UBS Group’s Calithera Biosciences, Inc CALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-321
Closed -$1.05K 10121
2022
Q4
$1.05K Hold
321
﹤0.01% 8776
2022
Q3
$1K Sell
321
-679
-68% -$2.12K ﹤0.01% 9140
2022
Q2
$3K Buy
1,000
+892
+826% +$2.68K ﹤0.01% 8440
2022
Q1
$1K Sell
108
-1,485
-93% -$13.8K ﹤0.01% 9070
2021
Q4
$22K Buy
1,593
+1,485
+1,375% +$20.5K ﹤0.01% 6648
2021
Q3
$5K Sell
108
-50
-32% -$2.32K ﹤0.01% 7452
2021
Q2
$7K Sell
158
-437
-73% -$19.4K ﹤0.01% 7290
2021
Q1
$29K Buy
595
+234
+65% +$11.4K ﹤0.01% 6040
2020
Q4
$36K Buy
361
+179
+98% +$17.9K ﹤0.01% 5492
2020
Q3
$12K Sell
182
-1,117
-86% -$73.6K ﹤0.01% 5853
2020
Q2
$137K Sell
1,299
-449
-26% -$47.4K ﹤0.01% 4268
2020
Q1
$155K Sell
1,748
-1,360
-44% -$121K ﹤0.01% 4081
2019
Q4
$355K Buy
3,108
+1,198
+63% +$137K ﹤0.01% 4176
2019
Q3
$118K Buy
1,910
+1,190
+165% +$73.5K ﹤0.01% 4752
2019
Q2
$56K Buy
720
+448
+165% +$34.8K ﹤0.01% 4968
2019
Q1
$36K Sell
272
-680
-71% -$90K ﹤0.01% 4974
2018
Q4
$76K Buy
+952
New +$76K ﹤0.01% 4889
2018
Q3
Sell
-37
Closed -$4K 7267
2018
Q2
$4K Buy
+37
New +$4K ﹤0.01% 6654
2018
Q1
Sell
-53
Closed -$9K 7159
2017
Q4
$9K Sell
53
-1,998
-97% -$339K ﹤0.01% 6142
2017
Q3
$646K Buy
2,051
+772
+60% +$243K ﹤0.01% 3284
2017
Q2
$380K Buy
1,279
+1,259
+6,295% +$374K ﹤0.01% 3526
2017
Q1
$5K Buy
+20
New +$5K ﹤0.01% 6083
2016
Q3
Sell
-160
Closed -$12K 6934
2016
Q2
$12K Buy
+160
New +$12K ﹤0.01% 5803
2016
Q1
Sell
-121
Closed -$19K 6960
2015
Q4
$19K Buy
+121
New +$19K ﹤0.01% 5613
2015
Q1
Sell
-83
Closed -$34K 6868
2014
Q4
$34K Buy
+83
New +$34K ﹤0.01% 5058